November/December 2010, Vol 3, No 6

Drugs don’t work in patients who don’t take them.”1—C. Everett Koop, MD, ScD, former US Surgeon General

Stakeholder Integration Crucial to Improved Patient Outcomes: Lessons from a Health Plan’s Experience

Asthma is one of the nation’s most common, costly, and increasingly prevalent diseases. In 2008, approximately 23.3 million people had asthma in the United States, of whom 12.7 million had experienced asthma attacks.1 The economic cost of asthma for 2010 is projected at $20.7 billion, of which $15.6 billion is expected to reflect direct costs of healthcare-related expenditures (ie, hospital care, physician services, and prescription drugs).1,2

Value-Based Insurance Design: Evolving Strategies to Improve Medication Adherence, Control Healthcare Utilization
Page 2 of 2
Results 11 - 12 of 12
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME